Endovascular Today53 分钟
NextBioMedical Receives IDE Approval for Pivotal Trial of Nexsphere-F Genicular Artery ...
NextBioMedical Co., Ltd., which is based in South Korea, announced that it has received investigational device exemption (IDE) ...